Partnership aims to advance Alzheimer’s research with innovative tools Cambridge Cognition Holdings plc has expanded its partnership with Actinogen Medical Limited for the phase 2b/3 […]
Treatment expands options for HER2-negative metastatic breast cancer AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use in Scotland. The approval by […]
The findings could benefit patients living with neurodegenerative conditions A new study published in the journal Neurology has suggested that as the […]